Synthetic Lethal Interactions with nucleophosMin 1

Project Information

SLIM

Grant agreement ID: 703668

DOI 10.3030/703668

Project terminated on 16 March 2018

EC signature date 15 March 2016

Start date 1 July 2016

End date 30 June 2018

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 178 156,80

EU contribution € 178 156,80

Coordinated by

CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH
Austria

Publications

Peer reviewed articles (2)

Global survey of the immunomodulatory potential of common drugs

Author(s): Gregory I Vladimer, Berend Snijder, Nikolaus Krall, Johannes W Bigenzahn, Kilian V M Huber, Charles-Hugues Lardeau, Kumar Sanjiv, Anna Ringler, Ulrika Warpman Berglund, Monika Sabler, Oscar Lopez de la Fuente, Paul Knöbl, Stefan Kubicek, Thomas Helleday, Ulrich Jäger, Giulio Superti-Furga
Published in: Nature Chemical Biology, Issue 13/6, 2017, Page(s) 681-690, ISSN 1552-4450
Publisher: Nature Publishing Group
DOI: 10.1038/nchembio.2360

Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study

Author(s): Berend Snijder, Gregory I Vladimer, Nikolaus Krall, Katsuhiro Miura, Ann-Sofie Schmolke, Christoph Kornauth, Oscar Lopez de la Fuente, Hye-Soo Choi, Emiel van der Kouwe, Sinan Gültekin, Lukas Kazianka, Johannes W Bigenzahn, Gregor Hoermann, Nicole Prutsch, Olaf Merkel, Anna Ringler, Monika Sabler, Georg Jeryczynski, Marius E Mayerhoefer, Ingrid Simonitsch-Klupp, Katharina Ocko, Franz Felberbauer,
Published in: The Lancet Haematology, Issue 4/12, 2017, Page(s) e595-e606, ISSN 2352-3026
Publisher: Elsevier Limited
DOI: 10.1016/S2352-3026(17)30208-9